Page 6,889«..1020..6,8886,8896,8906,891..6,9006,910..»

Iranian researcher helps treating muscular dystrophy using stem cells

Posted: Published on May 7th, 2012

Source: ISNA, Tehran Iranian researcher and lecturer Radbod Darabi jointly with his collogues from the University of Minnesota's Lillehei Heart Institute have effectively treated muscular dystrophy in mice using human stem cells derived from a new process which for the first time makes the production of human muscle cells from stem cells efficient and effective. Radbod Darabi, MD, PhD with Rita Perlingeiro, PhD. (Credit: Image courtesy of University of Minnesota Academic Health Center) The research outlines the strategy for the development of a rapidly dividing population of muscle-forming cells derived from induced pluripotent (iPS) cells. IPS cells have all of the potential of embryonic stem (ES) cells, but are derived by reprogramming skin cells. They can be patient-specific, which renders them unlikely to be rejected, and do not involve the destruction of embryos. This is the first time that human stem cells have been shown to be effective in the treatment of muscular dystrophy. According to the researchers, there has been a significant lag in translating studies using mouse stem cells into therapeutically relevant studies involving human stem cells. This lag has dramatically limited the development of cell therapies or clinical trials for human patients. The latest research from the … Continue reading →

Posted in Muscular Dystrophy Treatment | Comments Off on Iranian researcher helps treating muscular dystrophy using stem cells

treatment for autism – defeat autism now – treatments for autism – Video

Posted: Published on May 7th, 2012

06-05-2012 17:05 - treatment for autism - defeat autism now - treatments for autism He was affected very strongly by his social surroundings, and his emotions overloaded him every minute. Here's what I did to help, and here's what I've got to offer you. autism help resources for autism autism specialist autism treatment center autism teaching strategies cures for autism See the article here: treatment for autism - defeat autism now - treatments for autism - Video … Continue reading →

Comments Off on treatment for autism – defeat autism now – treatments for autism – Video

autism help – resources for autism – autism specialist – Video

Posted: Published on May 7th, 2012

06-05-2012 17:06 - autism help - resources for autism - autism specialist Due to all parents having extremely busy lifestyles, it can become like just another chore to have to listen and breakdown our children's. Daily experiences and issues, and even then we may struggle to have the right words. treatment for autism defeat autism now treatments for autism autism treatment center autism teaching strategies cures for autism See more here: autism help - resources for autism - autism specialist - Video … Continue reading →

Comments Off on autism help – resources for autism – autism specialist – Video

New 'spectrum' definition of autism worries parents as number diagnosed increases

Posted: Published on May 7th, 2012

April was Autism Awareness Month, but lately autism awareness seems to be a 24/7 and 365-days-a-year proposition. Researchers continue to look for a root cause, but the prevalence of autism is on the rise. In late March, the U.S. Centers for Disease Control and Prevention released a study saying that one in 88 children is diagnosed with having autism symptoms by age 8; that's up from one in 110 just six years ago. The numbers are even more alarming for boys -- one in 54. But perhaps more troubling to parents who already have a child diagnosed is the pending revision of the autism definition as it appears in the upcoming fifth edition of the Diagnostic and Statistical Manual of Mental Disorders. Publication of the new edition in May 2013 revises diagnostic criteria for psychiatric diagnoses. Members of the American Psychiatric Association are charged with refining the definition. The changes have been criticized by many parents and advocacy groups. Opinions from health professionals have spanned a wide spectrum. "It seems to be controversial," says Dr. Laura Murphy, chief of psychology at the University of Tennessee Health Science Center's Boling Center for Developmental Disabilities. "There are a couple of schools of … Continue reading →

Comments Off on New 'spectrum' definition of autism worries parents as number diagnosed increases

NeuroLogica Corporation Announces Partnership with MEYTEC GmbH

Posted: Published on May 7th, 2012

DANVERS, Mass.--(BUSINESS WIRE)-- NeuroLogica Corporation and German based MEYTEC GmbH announced today the development of the worlds first comprehensive mobile stroke ambulance. Stroke-Emergency-Mobile, VIMED STEMO, combines MEYTECs cutting-edge telemedicine solutions with NeuroLogicas state of the art portable CT scanner, CereTomTM. First conceived by the Charite-University Medicine Berlin, with the support of MEYTEC GmbH, VIMED STEMO is currently embedded in the emergency service system of Berlin. VIMED STEMO integrates a fully-functioning pre-clinical stroke care suite, comparable to most specialized stroke hospitals, with the added benefit of NeuroLogicas portable CereTomTM CT scanner. The pairing allows the on-board stroke physician to quickly evaluate, diagnose and treat the patient within the first hour of onset. Utilizing 3G, 4G, and satellite connectivity, VIMED STEMO will transmit fully-encrypted laboratory results, high-quality imaging and additional instruction to emergency rooms or trauma centers, greatly reducing time to treatment and possible mitigation of patient disability resulting from stroke. With the technological solution realized in STEMO, we have got a fascinating mobile facility that has already proven its technological stability and clinical usefulness in hundreds of cases, according to Prof. Heinrich Audebert of Charite-University Medicine and head of the Stroke-Emergency-Mobile consortium. Hyper-acute stroke care, including thrombolytic treatement before arrival at … Continue reading →

Comments Off on NeuroLogica Corporation Announces Partnership with MEYTEC GmbH

Amarantus BioSciences Issues First Annual CEO Letter to Shareholders

Posted: Published on May 7th, 2012

SUNNYVALE, Calif., May 7, 2012 /PRNewswire/ -- Amarantus BioSciences, Inc. (AMBS.OB), a biotechnology company developing the MANF Program for Parkinson's Disease and other brain disorders, today released a letter from President & CEO Gerald E. Commissiong to its shareholders: OUR MISSION Healing Patients For those among us who operate in this volatile, uncertain and challenging field of development-stage biotechnology, it is critical that healing patients always remains the top priority in each challenge we face. From the moment I took the helm as Chief Executive of Amarantus BioSciences, Inc. ("Amarantus", "Company", "we", or "us"), healing patients with Parkinson's disease has been front and center of my mission. In order to successfully translate the remarkable scientific advances our researchers and collaborators are making in the lab into F.D.A approved products improving lives throughout the world, we must also take into consideration another key stakeholder that supports the development and commercialization of new products in the healthcare system - the shareholder. Over the course of the last fifteen years, the many different companies that have brought revolutionary life-saving treatments to market for oncology patients worldwide, together, have definitively established that improvements in the understanding of molecular biology in the lab can lead … Continue reading →

Posted in Parkinson's Treatment | Comments Off on Amarantus BioSciences Issues First Annual CEO Letter to Shareholders

Watching miracles in Hungary unfold for cerebral palsy kids

Posted: Published on May 7th, 2012

Published Sunday, May 6, 2012, 8:19 AM Updated Sunday, May 6, 2012, 8:19 AM Budapest, Hungary Photo by Google Images In the hotel where I lodged while in Hungary recently, there were quite a number of families also staying there who had children affected mostly from the devastating illness cerebral palsy. The striking thing was that they were of all nationalities, and not just European. They were there from the US, South America, and Asia. Hungary, despite all its problems associated with poverty as it struggles to adjust to a new situation within the EU, are to the fore in the field of therapy associated with children afflicted with the ailment. The Peto Institute in Budapest, famed for its success in alleviating the symptoms and indeed greatly improving the lives of children with the condition, was near our hotel, and it was to there these families were either revisiting, or going there for first assessment. An American father, there with his wheelchair-bound eight-year-old little boy, told me: "This is my third trip to Hungary with Alan, and the improvement in him has been miraculous in a little over two years.There is a great understanding over here about his condition. For … Continue reading →

Posted in Cerebral Palsy Treatment | Comments Off on Watching miracles in Hungary unfold for cerebral palsy kids

CCSVI and MS Update – After the Move, May 5, 2012 – Video

Posted: Published on May 7th, 2012

05-05-2012 20:34 A short update after the big move and thoughts on the clogged jugular. Go here to read the rest: CCSVI and MS Update - After the Move, May 5, 2012 - Video … Continue reading →

Posted in MS Treatment | Comments Off on CCSVI and MS Update – After the Move, May 5, 2012 – Video

Wonderful Day For A Walk

Posted: Published on May 7th, 2012

Just because he wasn't at Allen Park on Sunday doesn't mean Doug Brown's presence wasn't felt. As Team DJ participated in the MS Walk in Allen Park on Sunday, Brown was in Buffalo receiving treatment for multiple sclerosis. Still, Brown's team was among the largest in attendance Sunday for the annual fundraiser. "We started out with just a few family members, but the team has just grown and grown," said Heather Brown of Team DJ. "We have around 60 people on the team this year and our goal is to raise at least $10,000 every year for the foundation. Doug (Brown) is missing the event for the first time this year because he is currently going through treatment for MS at Buffalo General Hospital." Brandy Wadsworth, the captain of Team Awesomeness, also has multiple sclerosis. "This team is all family and friends. I have MS so I'm doing these events while I can still walk. I want to be able to raise money for those people that can't," said Wadsworth. The National Multiple Sclerosis Society held its Walk MS Jamestown event Sunday, starting at the Allen Park Ice Rink, with hopes of raising more than $13,000 for the Upstate New … Continue reading →

Posted in MS Treatment | Comments Off on Wonderful Day For A Walk

Plenadren® (Hydrocortisone, Modified Release Tablet) Data Presented at 2012 Joint 15th International Congress of …

Posted: Published on May 7th, 2012

EXTON, Pennsylvania, May 7, 2012 /PRNewswire/ -- ViroPharma Incorporated today announced that three posters relating to long term data on Plenadren (hydrocortisone, modified release tablet) were presented at the 2012 joint 15th International Congress of Endocrinology and 14th European Congress of Endocrinology (ICE/ECE), held May 5 through 9, in Florence, Italy. Plenadren is the first true innovation in over 50 years in the treatment of adrenal insufficiency (AI), a rare and potentially life-threatening disease caused by insufficient cortisol production by the adrenal glands. In November 2011, the European Commission (EC) granted European Marketing Authorization for Plenadren (hydrocortisone, modified release tablet), an orphan drug for treatment of adrenal insufficiency in adults. ViroPharma anticipates commercial launch of Plenadren in the EU in the fourth quarter of 2012. Plenadren is not approved in the United States. However, it has received orphan drug designation status in the United States and has maintained orphan status in Europe upon approval. ICE/ECE Poster Presentations A poster entitled An Open, Multi-Centre, Phase IIIb, Long-Term Follow-up Study to Assess the Safety, Tolerability and Efficacy of Once-Daily Oral Dual-Release Hydrocortisone in Patients with Adrenal Insufficiency (#P78) described data from a long-term follow-up study in 71 patients with AI showing that … Continue reading →

Comments Off on Plenadren® (Hydrocortisone, Modified Release Tablet) Data Presented at 2012 Joint 15th International Congress of …

Page 6,889«..1020..6,8886,8896,8906,891..6,9006,910..»